Cathie Wood Adds to GLP-1 Holdings After Stock's 1,600% Decade Gain

On July 19, 2026, reports indicated that investor Cathie Wood is increasing her position in a GLP-1 stock that has delivered a staggering 1,600% return over the past ten years. The move underscores her strategy of betting on high-growth companies in the biotechnology sector. The specific stock was…

Cathie Wood's Latest Portfolio Move

Investor Cathie Wood is adding to her stake in a GLP-1 stock that has experienced massive growth over the last decade. The move was reported on July 19, 2026. Wood is known for her focus on disruptive innovation and often takes large positions in high-growth companies. Her decision to load up on this particular stock signals her continued confidence in its future prospects.

A Decade of Stunning Returns

The stock in question has soared 1,600% over the past ten years. This means that an investment made a decade ago would have grown to seventeen times its original value. Such a performance places it among the best-performing stocks in the market over that period. The 1,600% gain highlights the explosive growth potential of companies in the GLP-1 space.

The GLP-1 Sector Attracts Big Investors

GLP-1 stocks have become a focal point for investors seeking exposure to treatments for diabetes and weight loss. Wood's increased buying activity suggests she sees further upside for this particular company. The exact identity of the stock was not disclosed in the original report. However, her track record of investing in innovative biotech firms continues to draw attention from market observers.

Peptides referenced: GLP-1.